Why is methylphenidate preferred over amphetamines for cancer-related fatigue?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18647110
Cited by: 0

Abstract

Methylphenidate is preferred over amphetamines for managing cancer-related fatigue because of its proven effectiveness in reducing fatigue, better safety profile, and lower risk of psychotic symptoms, as supported by current clinical evidence and guidelines.

Fields of Study & Subjects

Cancer survivorship and care Cancer-related cognitive impairment studies Pain Management and Opioid Use

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 February 2026
Language
EN